Related Experiment Video

Updated: Jan 18, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.1K

Major changes in cervical cancer screening in the US

Keely K Ulmer1, Lisa F Soltani2, Ilana Addis3

  • 1Cancer Care Institute at Monument Health/Avera Research Institute, Rapid City, SD, United States of America.

Preventive Medicine
|January 16, 2026
PubMed
Summary

No abstract available in PubMed .

Keywords:
Interval frequencyPrimary HPV screeningPrimary care physiciansSelf-screeningUSPSTFWomen

More Related Videos

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

28.1K
Real-time Cytotoxicity Assays in Human Whole Blood
08:27

Real-time Cytotoxicity Assays in Human Whole Blood

Published on: November 7, 2014

12.7K

Related Experiment Videos

Last Updated: Jan 18, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.1K
RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

28.1K
Real-time Cytotoxicity Assays in Human Whole Blood
08:27

Real-time Cytotoxicity Assays in Human Whole Blood

Published on: November 7, 2014

12.7K

Related Concept Videos

Preventive Healthcare Services01:30

Preventive Healthcare Services

1.9K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.9K
Cancer Prevention02:59

Cancer Prevention

7.7K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.7K

Articles linked to this work by shared authors, journal, and citation graph.

A systematic meta-analytic comparative evaluation of seasonal influenza vaccine effectiveness from test-negative design studies in the Northern Hemisphere pre/post COVID-19 pandemic.

Vaccine·2026

Primary HPV Testing for Cervical Cancer Screening Among Family Medicine Educators.

Journal of the American Board of Family Medicine : JABFM·2026

Corrigendum to "Black US women share their experiences with follow-up after abnormal cervical cancer screening" [(2025) 100658 10].

Public health in practice (Oxford, England)·2026

Impact of Comorbidities on Survival among American Indian and Alaska Native People with Cancer: A Surveillance, Epidemiology, and End Results-Medicare Study.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026

Cervical Cancer Screening and Prevention among Latinas in the United States among a Network of Community Health Centers.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026

Serious Illness Communication Training in Family Medicine Residencies: A National Study of Program Director Perspectives.

Family medicine·2026

The MOTHER study as a foundation for advancing perinatal opioid use disorder treatment: Clinical guidelines and the evolving research landscape.

Preventive medicine·2026

Preliminary characterization of the timecourse and magnitude of e-cigarette withdrawal among exclusive e-cigarette users: Findings from a supervised withdrawal study.

Preventive medicine·2026

Association between adolescent alcohol consumption and cigarette smoking with adult risk of breast cancer: A systematic review and meta-analysis.

Preventive medicine·2026

Who bears the responsibility? Perceptions of responsibility for eating healthily and sustainably in a representative German sample.

Preventive medicine·2026

Behavioral economic demand analysis: A multidimensional framework for understanding drug reinforcement and tobacco science.

Preventive medicine·2026

Adverse childhood experiences and household firearm ownership: A large-scale analysis of specific risk factors among 15,771 adults from four U.S. states.

Preventive medicine·2026

NIR-Activated Enteric Prodrug Microparticles for Bioimaging-Guided Chemotherapy of Colorectal Cancer.

ACS applied materials & interfaces·2026

Protective effect of the bee bread on cadmium-induced testicular toxicity in rats.

Veterinary research forum : an international quarterly journal·2026

Stereotactic body radiotherapy for bone-only oligometastatic bladder Cancer: a multi-institutional experience.

Clinical and translational radiation oncology·2026

Neoadjuvant Early Stereotactic Body Radiation Therapy Followed by Chemoimmunotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer.

Advances in radiation oncology·2026

Exercise attenuates neuropathic pain and neuroinflammation in an obese rat model exhibiting diabetes-related metabolic dysfunction and features of type 2 diabetes.

IBRO neuroscience reports·2026

Efficacy and Safety of Sintilimab in Combination With Anlotinib and Chemoradiotherapy as First-Line Treatment for Driver Gene-Negative Oligometastatic Non-small Cell Lung Cancer: A Real-World Cohort Study.

Dose-response : a publication of International Hormesis Society·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us